The Electrospinning Company Ltd.

We design, develop and manufacture nanofibrous biomaterials for medical devices and regenerative medicine. Our technology platform is built on electrospinning and associated processing technologies. We are supporting clients with material development in a range of different therapeutic indications and territories, and supply electrospun biomaterial components into an FDA-approved medical device, the first such device to be sold in the USA. Originally a spin-out from the UK Science and Technology Facilities Council (STFC), we are located in a purpose-built cleanroom facility on the growing Harwell Science and Innovation Campus, near Oxford, in the UK.